As the diagnostic landscape evolves, several patterns are emerging across both clinical research and market innovation.

As you set New Year’s resolutions, add one that takes just minutes and can make a real difference: protect your skin and get ...

Squamous cell carcinoma is one of the most common and aggressive types of cancer in the head and neck region. It is the fifth ...

Indoor tanning is trending among Gen Z. A new study finds tanning bed users not only have a much higher risk of melanoma, ...

Scientists have uncovered how too much sunlight can flip a hidden switch inside skin cells that makes inflammation spiral out of control and increases the risk of cancer. Their research reveals that ...

A massive Veterans Affairs study has confirmed that nicotinamide may offer real protection against skin cancer. Patients who took the vitamin B3 derivative saw notable reductions in new cancer ...

A common vitamin could help prevent the development of skin cancer, new research suggests. The study, published in JAMA Dermatology, found a decreased risk of three types of skin cancer associated ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. A new study found nicotinamide supplements may cut the ...

A form of B3 called nicotinamide cut the risk of developing repeat skin cancers by as much as 54 percent, according to new research. A large new study found that nicotinamide, a form of vitamin B3, ...

Nicotinamide significantly reduces new skin cancer risk, especially when started early, with a 54% reduction after a first diagnosis. The study's findings align with previous trials, reinforcing ...

A large retrospective study of Veterans Affairs patients with a history of skin cancer has provided support to what a smaller randomized clinical trial reported about a decade ago: that patients ...

Nicotinamide reduced skin cancer risk by 14% overall in patients with a history of nonmelanoma skin cancer. The risk reduction increased to 54% when nicotinamide was started after a first skin cancer ...